Search Results (253)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Genetic basis of kidney cancer: a model for developing molecular-targeted therapies. | Academic Article |
Why?
|
| Novel molecular targeted therapies for refractory thyroid cancer. | Academic Article |
Why?
|
| Predicting response of molecular targeted therapies: a still possible challenge? | Academic Article |
Why?
|
| The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies. | Academic Article |
Why?
|
| A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain. | Academic Article |
Why?
|
| A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis. | Academic Article |
Why?
|
| A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma. | Academic Article |
Why?
|
| A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy. | Academic Article |
Why?
|
| A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies. | Academic Article |
Why?
|
| Adjuvant Therapy for Cutaneous Melanoma. | Academic Article |
Why?
|
| Alternatives to amyloid for Alzheimer's disease therapies-a symposium report. | Academic Article |
Why?
|
| Atherosclerosis: Recent trials, new targets and future directions. | Academic Article |
Why?
|
| Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia. | Academic Article |
Why?
|
| Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial. | Academic Article |
Why?
|
| Chemotherapy and targeted therapeutics as maintenance of response in advanced non-small cell lung cancer. | Academic Article |
Why?
|